NCT05076760 2025-08-29MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid TumorsMemgen, Inc.Phase 1 Recruiting40 enrolled
NCT05704985 2025-05-29Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA BiosciencesPhase 1 Active not recruiting39 enrolled
NCT04731467 2024-12-27A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid TumorsPurple Biotech Ltd.Phase 1/2 Completed79 enrolled
NCT03841110 2023-05-01FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid TumorsFate TherapeuticsPhase 1 Completed37 enrolled